Earlier this year, Pacific Biosciences founder and CTO Stephen Turner ran an animation of a real-time single-molecule sequence trace as a crawl at the foot of his slides for the duration of his talk, demonstratingÉ
Pacific Biosciences has demonstrated that it can use its single-molecule real-time sequencing technology to identify methylated DNA bases, and to directly sequence RNA molecules. It has also applied strobe sequencing,É
For over a decade, Eric Schadt has been one of a handful of scientists blending mathematics, biology and supercomputers to pursue a new understanding of human biology, one that suggests the mechanisms of human disease are far more complex than anticipated.
Pacific Biosciences said last week that it has raised $68 million in financing from a combination of new and existing investors, brining its total VC financing to more than $260 million since it was founded in 2004É
It took scientists more than twenty years after the first DNA sequencing technology was discovered to sequence the entire human genome; yet our own cells complete this task every time our bodies produces a daughter cell...
Eric Schadt, the Merck biomathematician whose groundbreaking studies on disease pathways and genome data integration have drawn plaudits from the scientific community, is joining the next-generation sequencing company Pacific Biosciences as Chief Scientific Officer.
Researchers at Pacific Biosciences have developed a new sequencing mode called "strobe sequencing" that enables them to increase the effective read length of their single-molecule real-time technology beyond 3 kilobasesÉ
Pacific Biosciences said last week that it has been named the senior party in an ongoing US Patent and Trademark Office interference that involves a patent held by Life Technologies and a patent application filed by PacBioÉ
In the race to "bring gene sequencing to the masses," Menlo Park's Pacific Biosciences planted its stake firmly in the ground Thursday night. At the Advances in Genome Biology and Technology conference in Florida, the company demonstrated a "real-time" gene sequencing of the...